- Trials with a EudraCT protocol (137)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
137 result(s) found for: Molecular pathology.
Displaying page 1 of 7.
EudraCT Number: 2017-001691-39 | Sponsor Protocol Number: UKM17_0023 | Start Date*: 2019-07-16 | |||||||||||
Sponsor Name:University Hospital Münster | |||||||||||||
Full Title: LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma | |||||||||||||
Medical condition: Lymphoblastic lymphoma | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Trial now transitioned) DE (Ongoing) DK (Trial now transitioned) IE (Completed) NO (Trial now transitioned) FI (Trial now transitioned) AT (Trial now transitioned) CZ (Trial now transitioned) SE (Trial now transitioned) ES (Ongoing) NL (Ongoing) SK (Trial now transitioned) HU (Trial now transitioned) PL (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005717-40 | Sponsor Protocol Number: 2001-FIVI-002-IC | Start Date*: 2021-05-05 |
Sponsor Name:IVI Foundation | ||
Full Title: Umbilical cord plasma for treating endometrial pathologies (thin endometrium / Ash erman’s syndrome/ endometria atrophy) | ||
Medical condition: Endometrial pathologies (Thin endometrium/ Asherman's syndrome/ Endometrial atrophy) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002849-11 | Sponsor Protocol Number: FIRE-5 | Start Date*: 2019-06-17 | |||||||||||
Sponsor Name:Klinikum der Universität München, Ludwig-Maximilians-Universität München, represented by the managing medical director | |||||||||||||
Full Title: Optimal anti-EGFR Treatment of mCRC Patients with Low-Frequency RAS Mutation | |||||||||||||
Medical condition: RAS-mutant metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000315-76 | Sponsor Protocol Number: 1375_RCF_MAC | Start Date*: 2021-12-06 | |||||||||||
Sponsor Name:Centro Hospitalar Universitário de Lisboa Central, EPE | |||||||||||||
Full Title: Low molecular weight heparin in the treatment of early fetal growth restriction | |||||||||||||
Medical condition: Early fetal growth restriction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: PT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001803-35 | Sponsor Protocol Number: DCC-2618-03-002 | Start Date*: 2019-04-01 | |||||||||||
Sponsor Name:Deciphera Pharmaceuticals, LLC | |||||||||||||
Full Title: A Phase 3, Interventional, Randomized, Multicenter, Open-Label Study of DCC-2618 vs Sunitinib in Patients with Advanced Gastrointestinal Stromal Tumors after Treatment with Imatinib | |||||||||||||
Medical condition: Patients with Advanced Gastrointestinal Stromal Tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Trial now transitioned) CZ (Completed) NO (Trial now transitioned) ES (Ongoing) SE (Completed) BE (Completed) NL (Trial now transitioned) HU (Completed) PL (Completed) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002654-79 | Sponsor Protocol Number: P160954J | Start Date*: 2019-02-13 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: TEMOTRAD 01 : First-line chemotherapy with temozolomide alone for non-enhancing adult brainstem gliomas, with a diffuse subtype and showing clinical and/or radiological infiltrative pattern of pro... | |||||||||||||
Medical condition: adult brainstem gliomas | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022422-32 | Sponsor Protocol Number: RHMCAN0749 | Start Date*: 2010-12-20 |
Sponsor Name:University Hospital Southampton NHS Foundation Trust | ||
Full Title: A randomised evaluation of molecular guided therapy for diffuse large B-cell lymphoma with Bortezomib | ||
Medical condition: Diffuse Large B-cell Lymphoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000035-25 | Sponsor Protocol Number: ET-B-028-06 | Start Date*: 2007-07-13 | |||||||||||
Sponsor Name:Pharma Mar, S.A. | |||||||||||||
Full Title: A Multicenter Phase II Clinical Trial of Neoadjuvant Trabectedin (Yondelis®) in Patients with Localized Myxoid / Round Cell Liposarcoma | |||||||||||||
Medical condition: Localized myxoid / round cell liposarcoma previously untreated with chemotherapy or radiation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004537-25 | Sponsor Protocol Number: ET16-116 | Start Date*: 2017-11-06 | |||||||||||
Sponsor Name:Centre Léon Bérard | |||||||||||||
Full Title: An Phase II trial aiming to evaluate the clinical interest of ABEMACICLIB monotherapy in patients with locally advanced/metastatic head and neck cancer after failure of platinum and cetuximab or an... | |||||||||||||
Medical condition: Patients with locally advanced/metastatic head and neck cancer after failure of platinum and cetuximab or anti-EGFR-based | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003389-42 | Sponsor Protocol Number: DASA-PEGIFN | Start Date*: 2013-06-26 | |||||||||||
Sponsor Name:CHU DE POITIERS | |||||||||||||
Full Title: A phase II study to assess the efficacy and safety of frontline combination of dasatinib (SPRYCEL®) and pegylated-interferon alpha 2b (Peg-IFNα2b) therapy in patients newly diagnosed with chronic p... | |||||||||||||
Medical condition: Patients with newly diagnosed chronic phase Chronic Myeloid Leukemia (CP-CML), not previously treated with Tyrosine Kinase Inhibitors (TKIs). First line therapy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-003335-29 | Sponsor Protocol Number: SIOPEATRT01 | Start Date*: 2021-04-15 |
Sponsor Name:German Pediatric Oncology Group, GPOH gGmbH | ||
Full Title: An international prospective umbrella trial for children with atypical teratoid/rhabdoid tumours (ATRT) including A randomized phase III study evaluating the non-inferiority of three courses of hig... | ||
Medical condition: atypical teratoid/rhabdoid tumours (ATRT) | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: DE (Ongoing) NO (Trial now transitioned) NL (Trial now transitioned) DK (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004837-16 | Sponsor Protocol Number: CRAD001C2454 | Start Date*: 2006-10-04 |
Sponsor Name:Novartis Pharma GmbH | ||
Full Title: Multicenter, single-arm, two-stage phase II trial of RAD001 (everolismus) with Glivec® in Glivec®-resistant patients with progressive GIST | ||
Medical condition: gastrointestinal stromal tumors (GIST) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-002893-38 | Sponsor Protocol Number: CA209-8PA | Start Date*: 2019-03-05 | |||||||||||
Sponsor Name:GRUPPO ONCOLOGICO ITALIANO DI RICERCA CLINICA (GOIRC) | |||||||||||||
Full Title: Phase II Study on NIVolumab in combination with FOLFOXIRI/Bevacizumab in first line chemotherapy of Advanced COloRectal cancer RASm/BRAFm patients | |||||||||||||
Medical condition: Advanced colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-008323-15 | Sponsor Protocol Number: CR12 | Start Date*: 2009-06-12 | |||||||||||
Sponsor Name:Medical Research Council | |||||||||||||
Full Title: FOCUS 3 A study to determine the feasibility of molecular selection of therapy using KRAS, BRAF and topo-1 in patients with metastatic or locally advanced colorectal cancer. | |||||||||||||
Medical condition: metastatic or locally advanced colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005702-39 | Sponsor Protocol Number: O08-1 | Start Date*: 2009-03-16 | |||||||||||
Sponsor Name:GERCOR | |||||||||||||
Full Title: Phase I/II study of Induction Chemotherapy with weekly RAD001, Carboplatine and Paclitaxel in Unresectable or Inoperable Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) | |||||||||||||
Medical condition: Unresectable or Inoperable locally advanced head and neck squamous cell carcinoma without any prior chemotherapy or radiotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000518-40 | Sponsor Protocol Number: RAINBO-MMRd-GREEN-ENGOT-EC14_02 | Start Date*: 2022-01-17 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials - The MMRD-GREEN trial - | ||
Medical condition: Endometrial Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-000284-21 | Sponsor Protocol Number: 524E-CVD-9101-004 | Start Date*: 2007-11-08 | |||||||||||
Sponsor Name:York Hospitals NHS Foundation Trust [...] | |||||||||||||
Full Title: A multicentre, multinational randomised control trial of prophylactic low molecular weight heparin(LMWH) in high risk pregnant thrombophilic women | |||||||||||||
Medical condition: Thrombophilia in pregnancy. This is a multi-centre, multi-national randomised controlled trial of Low Molecular Weight Heparin to prevent pregnancy complications in high-risk pregnant thrombophi... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002523-26 | Sponsor Protocol Number: WI88341 | Start Date*: 2016-03-08 | |||||||||||
Sponsor Name:Arthritis Alapítvány | |||||||||||||
Full Title: Effects of JAK inhibition on rheumatoid arthritis-related comorbidities: link between bone and vascular effects (investigator-initiated grant proposal) | |||||||||||||
Medical condition: Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-006454-30 | Sponsor Protocol Number: 23537 | Start Date*: 2023-02-09 | ||||||||||||||||
Sponsor Name:DIPARTIMENTO DI SCIENZE CHIRURGICHE - UNIVERSITà DEGLI STUDI DI TORINO | ||||||||||||||||||
Full Title: Near-infrared molecular imaging for lung cancer detection and treatment during mini-invasive surgery (Phase II Trial) | ||||||||||||||||||
Medical condition: To date, lung resection and lymphadenectomy remains the best curative option in patients with early-stage non-small cell lung cancer. Moreover, cancer screening programs have led to a frequent diag... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003836-77 | Sponsor Protocol Number: OCTO-003 | Start Date*: 2008-12-09 |
Sponsor Name:University of Oxford | ||
Full Title: AspECT - A phase III, randomised study of aspirin and esomeprazole chemoprevention in Barrett's metaplasia & oesophagitis. | ||
Medical condition: Barrett's Metaplasia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
